Feature Channels: Blood

Filters close
Newswise: Cedars-Sinai July Research Highlights
Released: 28-Jul-2023 11:50 AM EDT
Cedars-Sinai July Research Highlights
Cedars-Sinai

A roundup of the latest medical discoveries and faculty news at Cedars-Sinai.

Newswise: Cedars-Sinai Cancer Welcomes Hematologist-Oncologist Niki Patel, MD
Released: 27-Jul-2023 3:35 PM EDT
Cedars-Sinai Cancer Welcomes Hematologist-Oncologist Niki Patel, MD
Cedars-Sinai

Niki Patel, MD, a fellowship-trained hematologist-oncologist board certified in internal medicine and medical oncology, has joined the Division of Medical Oncology at Cedars-Sinai Cancer. She is treating patients in Pasadena at Huntington Cancer Center at Huntington Health, an affiliate of Cedars-Sinai.

Released: 27-Jul-2023 2:25 PM EDT
Lab on a chip technologies to improve the assessment of stored red blood cells
Massachusetts General Hospital

Lab-on-a-chip technologies can ensure a more successful transfusion workflow by enabling objective assessment of stored RBC units using quality metrics identified by -omics and machine learning.

   
24-Jul-2023 11:10 AM EDT
CHOP and Penn Medicine Researchers Develop “In Vivo” RNA-based Gene Editing Model for Blood Disorders
Children's Hospital of Philadelphia

In a step forward in the development of genetic medicines, researchers at Children’s Hospital of Philadelphia (CHOP) and the Perelman School of Medicine at the University of Pennsylvania have developed a proof-of-concept model for delivering gene editing tools to treat blood disorders, allowing for the modification of diseased blood cells directly within the body. If translated into the clinic, this approach could expand access and reduce the cost of gene therapies for blood disorders, many of which currently require patients receive chemotherapy and a stem cell transplant. The findings were published today in the journal Science.

Newswise: Yale Scientists Develop a New Approach to Strengthen CAR-T Cell Therapy
Released: 27-Jul-2023 11:55 AM EDT
Yale Scientists Develop a New Approach to Strengthen CAR-T Cell Therapy
Yale Cancer Center/Smilow Cancer Hospital

Chimeric antigen receptor (CAR)-T cells are a powerful, new form of cancer therapy that are being studied to treat blood cancers. Using a new approach, Yale Cancer Center researchers at Yale School of Medicine found a new way to substantially improve the effectiveness of CAR-T cell therapy. The new study was published in Nature Immunology on July 27.

Newswise: The Medical Minute: Donated blood kept free from pathogens
Released: 27-Jul-2023 8:40 AM EDT
The Medical Minute: Donated blood kept free from pathogens
Penn State Health

Blood banks always say it’s safe to give blood. But is it safe to receive? A Penn State Health expert discusses all the ways professionals keep your blood pathogen-free.

Not for public release

This news release is embargoed until 26-Jul-2023 5:00 PM EDT Released to reporters: 26-Jul-2023 3:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Research pinpoints inflammation source behind atherosclerosis
Released: 25-Jul-2023 11:15 AM EDT
Research pinpoints inflammation source behind atherosclerosis
UT Southwestern Medical Center

Scientists at UT Southwestern Medical Center and Children’s Medical Center Dallas have discovered in mice how high cholesterol causes blood vessels to become inflamed, a necessary prerequisite for atherosclerosis – the “hardening of the arteries” responsible for most heart attacks and strokes. The findings, published in Nature Communications, could lead to new interventions to protect against cardiovascular diseases (CVD), the leading cause of death globally.

Newswise: When Blood Is a New Alternative Medicine for Pain Relief at Chula Pain Clinic
Released: 25-Jul-2023 8:55 AM EDT
When Blood Is a New Alternative Medicine for Pain Relief at Chula Pain Clinic
Chulalongkorn University

Chula Medicine researchers have successfully published an article on the injection of patient’s own platelets rich plasma into the shoulder ligaments resulting in pain reduction, heal torn ligaments and restore torn muscles as an alternative to surgery while reducing the side effects of prolonged use of pain medications.

Released: 24-Jul-2023 2:05 PM EDT
New Day Diagnostics LLC Reinforces Commitment to Early Cancer Intervention with Its intention to Acquire the Assets of Epigenomics AG
2023 AACC Annual Scientific Meeting Press Program

New Day Diagnostics LLC is pleased to announce that it has entered into an asset purchase agreement with Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), a molecular diagnostics company focused on blood testing for the early detection of cancer.

Newswise: Research Reveals Blood Platelets Play Important Role in Kawasaki Disease
Released: 24-Jul-2023 11:30 AM EDT
Research Reveals Blood Platelets Play Important Role in Kawasaki Disease
Cedars-Sinai

Cedars-Sinai Guerin Children’s investigators have advanced our understanding of the role that blood platelets play in Kawasaki disease, a serious illness that primarily affects children younger than 5 years old and causes their blood vessels to swell.

Released: 24-Jul-2023 8:40 AM EDT
Gene Variant May Help Explain Why Black Individuals Are Prone to Severe Strokes
University of Utah Health

In a new study, University of Utah Health researchers have shown that a particular version of a gene may contribute to the higher severity of stroke seen among Black Americans. The findings could help scientists develop more effective stroke medications for people who carry the gene.

19-Jul-2023 10:00 AM EDT
Microbiome-Directed Therapies for Undernutrition, Big Data for Precision Medicine, Health Equity, and More to Be Explored at 2023 AACC Annual Scientific Meeting & Clinical Lab Expo
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

At the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo, laboratory experts will present cutting-edge research and technology that is shaping the future of clinical testing and patient care.

Newswise: At an event in California, a Brazilian health tech company presented its exclusive technology for blood tests with AI, delivering results within 30 minutes
Released: 21-Jul-2023 4:20 PM EDT
At an event in California, a Brazilian health tech company presented its exclusive technology for blood tests with AI, delivering results within 30 minutes
2023 AACC Annual Scientific Meeting Press Program

During the AACC - Annual Scientific Meeting & Clinical Lab Expo, held in Anaheim, California (USA) from July 23rd to 27th, the Brazilian health tech company Hilab, specializing in clinical analysis tests, participated in the congress alongside ABIMO - Brazilian Association of Medical Devices Industry.

   
Released: 19-Jul-2023 4:20 PM EDT
New Innovation in CAR T-Cells Paves Way for Less Toxic Therapy Against Multiple Myeloma
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) researchers engineered a new type of CAR T-cell therapy that, in preclinical studies, selectively attacked cancer cells while sparing healthy cells, potentially reducing the likelihood of toxic side effects from this innovative cancer treatment.

Released: 19-Jul-2023 12:00 PM EDT
MD Anderson Research Highlights for July 19, 2023
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Newswise: NUS researchers develop novel approach for predicting resistance against cancer therapy
Released: 18-Jul-2023 10:00 PM EDT
NUS researchers develop novel approach for predicting resistance against cancer therapy
National University of Singapore (NUS)

A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS), led by Assistant Professor Anand Jeyasekharan, has discovered a unique combination of oncogenes that could predict treatment resistance, and hence unfavourable outcomes, of patients with Diffuse large B cell lymphoma (DLBCL), the most common type of blood cancer in Singapore and globally.

Released: 12-Jul-2023 12:35 PM EDT
Blood pressure patterns in the first half of pregnancy improve early prediction of preeclampsia and gestational hypertension
Kaiser Permanente

Routine blood pressure readings recorded in the first half of pregnancy can be divided into 6 distinct patterns that can effectively stratify patients by their risk of developing preeclampsia and gestational hypertension later in pregnancy, Kaiser Permanente researchers found.

Newswise: Study finds new potential therapy option for patients with chronic lymphocytic leukemia
Released: 6-Jul-2023 11:25 AM EDT
Study finds new potential therapy option for patients with chronic lymphocytic leukemia
Ohio State University Wexner Medical Center

Researchers continue to refine and improve targeted drug therapies that have changed the most common form of adult leukemia – from an incurable to a chronic condition. New data published in the New England Journal of Medicine offers another treatment option for patients who have stopped responding to the first and second generation drugs.

Newswise: Base editing shows potential superiority for curing sickle cell disease
Released: 3-Jul-2023 11:00 AM EDT
Base editing shows potential superiority for curing sickle cell disease
St. Jude Children's Research Hospital

Gene therapy that alters hemoglobin genes may be an answer to curing sickle cell disease and beta thalassemia. Scientists at St. Jude Children’s Research Hospital and the Broad Institute of MIT and Harvard found base editing increased fetal hemoglobin production in a new treatment.

Released: 29-Jun-2023 5:25 PM EDT
New research shows promise for drug to lessen side effects of blood thinning drugs for stroke patients with bleeding in the brain
University of Nottingham

The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to be used to lessen the side effects of blood-thinning drugs for patients who have experienced a stroke.

Released: 29-Jun-2023 11:00 AM EDT
Study suggests need for iron tests in teen girls & young women
Michigan Medicine - University of Michigan

A national study of blood ferritin and hemoglobin levels from tween, teen and young adult females suggests routine screening might be needed for iron deficiency and anemia.

27-Jun-2023 4:00 PM EDT
Blood test aids in predicting lung cancer mortality risk
University of Texas MD Anderson Cancer Center

A blood-based four-protein panel (4MP), when combined with a lung cancer risk model (PLCOm2012), can better identify those at high risk of dying from lung cancer than the current U.S. Preventive Services Task Force (USPSTF) criteria.

Newswise: All-in-one device for hemorrhage control
Released: 28-Jun-2023 2:55 PM EDT
All-in-one device for hemorrhage control
Terasaki Institute for Biomedical Innovation

A multi-faceted device for effectively treating deep, non-compressible, and irregularly-shaped wounds has been engineered by the scientists at the Terasaki Institute for Biomedical Innovation (TIBI).

27-Jun-2023 8:00 AM EDT
Antibody Treatment Prevents Graft Versus Host Disease, a Major Bone Marrow Transplant Complication, in Advanced Preclinical Tests
Perelman School of Medicine at the University of Pennsylvania

An experimental antibody treatment largely prevented a bone marrow transplant complication called graft versus host disease (GVHD) in the intestines, without causing broad immune suppression, in a preclinical study led by researchers from Penn Medicine and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center and published today in Science Translational Medicine.

Released: 27-Jun-2023 2:05 PM EDT
Four Midwest centers unite to advance novel therapeutics
Michigan Medicine - University of Michigan

A new collective named the Great Lakes Clinical Center (GLCC) for the ARDS, Pneumonia and Sepsis (APS) Phenotyping Consortium will be intensely focused on examining the various mechanisms underpinning these conditions to better understand their impact on disease development, trajectory and outcomes.

Not for public release

This news release is embargoed until 26-Jun-2023 5:00 PM EDT Released to reporters: 20-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 26-Jun-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Novel Study Deepens Knowledge of Treatment-Resistant Hypertension
Released: 26-Jun-2023 10:55 AM EDT
Novel Study Deepens Knowledge of Treatment-Resistant Hypertension
Cedars-Sinai

For many patients with hypertension—an elevated blood pressure that can lead to stroke or heart attack—medication keeps the condition at bay. But what happens when medication that physicians usually prescribe doesn’t work? Known as apparent resistant hypertension (aRH), this form of high blood pressure requires more medication and medical management.

Released: 26-Jun-2023 9:45 AM EDT
Pessoas com obesidade mórbida e uma variante genética apresentam maior risco de hipertensão, revela pesquisa da Mayo Clinic
Mayo Clinic

Pessoas com obesidade grave e uma variante genética específica correm maior risco de pressão alta, descobriu um estudo da Mayo Clinic.

Released: 26-Jun-2023 9:05 AM EDT
Las personas con obesidad grave y una variante de vía genética corren un mayor riesgo de tener hipertensión, según una investigación de Mayo Clinic
Mayo Clinic

Las personas con obesidad severa y una variante genética específica tienen un mayor riesgo de hipertensión, según descubrió un estudio de Mayo Clinic.

Released: 26-Jun-2023 12:05 AM EDT
توصلت أبحاث Mayo Clinic أن من يعانون من السُمنة المفرطة وأحد المتغيرات الجينية، عرضة أكثر للإصابة بارتفاع ضغط الدم
Mayo Clinic

مع السمنة ، يزداد خطر الإصابة بأمراض القلب والأوعية الدموية ، والتي تشمل السكتة الدماغية وفشل القلب الاحتقاني واحتشاء عضلة القلب. السمنة مرض متعدد العوامل ينتج عن اختلال توازن الطاقة. السمنة عامل خطر قابل للتعديل لأمراض القلب والأوعية الدموية.

Released: 22-Jun-2023 5:35 PM EDT
Switch to MR angiography for PE mitigated impact of recent contrast shortage
American Roentgen Ray Society (ARRS)

According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), preferential use of pulmonary MR angiography (MRA) for diagnosing pulmonary embolus (PE) in the general population helped conserve iodinated contrast media during the 2022 shortage.

   
Newswise: Portable Tool to Diagnose and Monitor Sickle Cell Disease Receives U.S. Patent
Released: 22-Jun-2023 8:30 AM EDT
Portable Tool to Diagnose and Monitor Sickle Cell Disease Receives U.S. Patent
Florida Atlantic University

A new tool will enable patients with sickle cell disease to reliably and conveniently monitor their disease in the same way patients with diabetes can monitor their disease using a glucometer. The goal of managing this inherited, lifelong blood disorder is to prevent acute, painful crises due to sickling and unsickling of red blood cells.

   
Released: 21-Jun-2023 3:10 PM EDT
Screening newborns for "bubble-baby" disease saves lives
Universite de Montreal

Survival rates of babies after bone-marrow transplants jumped significantly after screening for SCID – severe combined immunodeficiency disease – started in North America in 2008, a major study finds.

Newswise:Video Embedded hot-yoga-offsets-negative-effects-of-high-salt-diet-on-blood-pressure-in-black-women
VIDEO
Released: 21-Jun-2023 10:00 AM EDT
Hot Yoga Offsets Negative Effects of High-salt Diet on Blood Pressure in Black Women
American Physiological Society (APS)

Participating in hot yoga over four weeks reduced blood pressure in Black women, according to a study from Texas State University. Researchers also found the blood pressure drop and a widening of the participants’ arteries occurred despite three days of high salt intake.

Newswise: Exercise May Induce Strokes for People with Blocked Arteries
16-Jun-2023 10:35 AM EDT
Exercise May Induce Strokes for People with Blocked Arteries
American Institute of Physics (AIP)

Certain conditions can make the increased heart rate associated with exercise dangerous: Researchers found that an elevated heart rate can induce a stroke in patients with highly blocked carotid arteries. Contrastingly, for healthy patients and those with only slightly blocked arteries, exercise is beneficial for maintaining healthy blood flow. In healthy patients, an elevated heart rate increases and stabilizes the drag force blood exerts on the vessel wall, reducing stenosis risk. But for patients already experiencing stenosis, it may not be as beneficial.

   
Released: 20-Jun-2023 10:05 AM EDT
Veravas Launches Groundbreaking VeraBIND Technology for Ultra-Sensitive Assays and Matrix Free Sample Analysis
Veravas, Inc

Today, Veravas, a leading innovator in clinical diagnostics, announced the launch of its groundbreaking VeraBIND™ (Biomarker Isolation and N-richment for Detection) technology

   
Released: 20-Jun-2023 10:00 AM EDT
Cholesterol lures in coronavirus
American Society for Biochemistry and Molecular Biology (ASBMB)

New study shows that cholesterol aggregates can promote SARS-CoV-2 infection to help the virus invade cells

Not for public release

This news release is embargoed until 19-Jun-2023 5:00 PM EDT Released to reporters: 13-Jun-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-Jun-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Hackensack University Medical Center Investigators Present Pioneering Research at Annual Pediatric Cancer Meeting
Released: 19-Jun-2023 12:05 PM EDT
Hackensack University Medical Center Investigators Present Pioneering Research at Annual Pediatric Cancer Meeting
Hackensack Meridian Health

Researchers from Hackensack Meridian Children's Health at Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center presented seven studies at the American Society of Pediatric Hematology/Oncology (ASPHO) Conference in Fort Worth in May.

Released: 14-Jun-2023 1:15 PM EDT
The heat is on! Don't panic. Get the latest news on heat waves and the dangers of heat in the Extreme Heat channel
Newswise

As we enter the summer months in the Northern Hemisphere and the possibility of extreme heat becomes more common, it’s important to stay up-to-date on the science of heat waves and take measures to protect ourselves from this growing public health threat.

       
Released: 14-Jun-2023 12:45 PM EDT
UK Army & NHSBT Dry Plasma Development Contract Awarded to Velico
Velico Medical, Inc

An innovative project to rapidly deliver blood and plasma to injured soldiers is set to save lives in warzones. The UK Ministry of Defence's Blood Far Forward programme aims to deliver blood and plasma within 30 minutes of injury to soldiers in active warzones.

   
Released: 13-Jun-2023 8:50 AM EDT
Kyowa Kirin Launches Effort to Educate Healthcare Providers on Blood Involvement in Mycosis Fungoides and Sézary Syndrome
Kyowa Kirin, Inc.

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company, today announced an initiative, Proactively Recognizing Occurrence in Blood through Education (PROBE) housed on PROBEinCTCL.com which was developed to educate HCPs on the importance of assessing blood involvement in Sézary Syndrome and Mycosis Fungoides—two subtypes of cutaneous T-cell lymphoma (CTCL).

Newswise: Thriving After, Not Merely Surviving, Cancer
Released: 12-Jun-2023 12:10 PM EDT
Thriving After, Not Merely Surviving, Cancer
Cedars-Sinai

Carlos Rene Valdez’s dance through life was interrupted by a cancer diagnosis, but it was the struggle to move on after recovery that ended his career and threatened his life. Wellness, Resilience and Survivorship programming, a part of the Patient and Family Support Program at Cedars-Sinai Cancer, gave him his life back.

Released: 12-Jun-2023 11:05 AM EDT
Newly approved blood test can help predict severe preeclampsia diagnoses earlier and more accurately
University of Chicago Medical Center

A first-of-its-kind prognostic test approved by the FDA can now help doctors in the United States predict whether a woman will develop severe preeclampsia during pregnancy.

Newswise: Study brings new understanding of multiple myeloma evolution
9-Jun-2023 1:45 PM EDT
Study brings new understanding of multiple myeloma evolution
University of Texas MD Anderson Cancer Center

A new study by researchers at The University of Texas MD Anderson Cancer Center highlights novel insights into the evolution of multiple myeloma from precursor disease, which may help better identify patients likely to progress and develop new interventions

7-Jun-2023 2:00 PM EDT
Novel Gene Therapy Shows Positive Initial Results in Sickle Cell Patients Treated in Clinical Trial at Cleveland Clinic Children’s
Cleveland Clinic

Researchers presenting preliminary data from a clinical trial aimed at discovering a cure for sickle cell disease reveal positive results among its first patients. Sickle cell disease, a genetic blood disorder, is a painful and debilitating condition for which there are few approved therapies.

Newswise: Combining bioprinting techniques to pursue functional blood vessels
Released: 7-Jun-2023 1:05 PM EDT
Combining bioprinting techniques to pursue functional blood vessels
University Medical Center Utrecht

In this project volumetric bioprinting was for the first time successfully combined with melt electrowriting.

Released: 7-Jun-2023 12:00 PM EDT
MD Anderson Research Highlights for June 7, 2023
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention.

   


close
1.79975